american oncology network inc - AONC

AONC

Close Chg Chg %
7.45 3.55 47.65%

Open Market

11.00

+3.55 (47.65%)

Volume: 100.00

Last Updated:

Jan 22, 2026, 11:19 AM EDT

Company Overview: american oncology network inc - AONC

AONC Key Data

Open

$11.00

Day Range

11.00 - 11.00

52 Week Range

0.00 - 14.25

Market Cap

$217.30M

Shares Outstanding

29.17M

Public Float

8.29M

Beta

0.78

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.29

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

93.62

 

AONC Performance

1 Week
 
-36.60%
 
1 Month
 
-33.00%
 
3 Months
 
-14.37%
 
1 Year
 
41.10%
 
5 Years
 
N/A
 

AONC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About american oncology network inc - AONC

American Oncology Network, Inc. engages in the provision of community-based oncology management. The firm provides various services to patients, including laboratory services for routine and specialized testing, in-house professional and technical pathology services with pathology reports, in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance, and care management support services, including nutrition guidance. The company was founded in 2018 and is headquartered in Fort Myers, FL.

AONC At a Glance

American Oncology Network, Inc.
14543 Global Parkway
Fort Myers, Florida 33913
Phone 1-833-886-1725 Revenue 1.76B
Industry Medical/Nursing Services Net Income -3,973,000.00
Sector Health Services 2024 Sales Growth 37.547%
Fiscal Year-end 12 / 2025 Employees 1,914
View SEC Filings

AONC Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.039
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA 91.993
Enterprise Value to Sales 0.171
Total Debt to Enterprise Value 0.50

AONC Efficiency

Revenue/Employee 919,270.637
Income Per Employee -2,075.758
Receivables Turnover 9.279
Total Asset Turnover 4.166

AONC Liquidity

Current Ratio 1.529
Quick Ratio 1.249
Cash Ratio 0.335

AONC Profitability

Gross Margin 5.597
Operating Margin -0.915
Pretax Margin -1.399
Net Margin -0.226
Return on Assets -0.941
Return on Equity N/A
Return on Total Capital -2.344
Return on Invested Capital -4.283

AONC Capital Structure

Total Debt to Total Equity 803.069
Total Debt to Total Capital 88.927
Total Debt to Total Assets 32.051
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 81.714
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for American Oncology Network Inc - AONC

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
- - 1.28B 1.76B
-
Sales Growth
- - - +37.55%
-
Cost of Goods Sold (COGS) incl D&A
- - 1.21B 1.66B
-
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- - 16.74M 19.37M
-
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
- - - +36.92%
-
Gross Income
- - 66.06M 98.47M
-
Gross Income Growth
- - - +49.08%
-
Gross Profit Margin
- - +5.16% +5.60%
-
2021 2022 2023 2024 5-year trend
SG&A Expense
1.63M 2.39M 83.97M 114.57M
Research & Development
- - - -
-
Other SG&A
1.63M 2.39M 83.97M 114.57M
SGA Growth
- +46.40% +3,413.75% +36.43%
Other Operating Expense
- - - -
-
Unusual Expense
(10.01M) (8.82M) 21.94M (10.56M)
EBIT after Unusual Expense
8.37M 6.43M (39.85M) (5.53M)
Non Operating Income/Expense
20.26K 5.13M (16.24M) (12.03M)
Non-Operating Interest Income
20.26K 5.13M 1.33M 3.20M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - 6.42M 7.06M
-
Interest Expense Growth
- - - +9.97%
-
Gross Interest Expense
- - 6.42M 7.06M
-
Interest Capitalized
- - - -
-
Pretax Income
8.39M 11.56M (62.51M) (24.61M)
Pretax Income Growth
+1,006,661.03% +37.69% -640.76% +60.62%
Pretax Margin
- - -4.89% -1.40%
-
Income Tax
- 1.03M 384.00K 2.50M
Income Tax - Current - Domestic
- - 585.28K (236.00K)
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- 441.36K 384.00K 2.73M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
8.39M 10.53M (63.15M) (26.96M)
Minority Interest Expense
- - (57.61M) (22.98M)
-
Net Income
8.39M 10.53M (5.54M) (3.97M)
Net Income Growth
+1,006,661.03% +25.47% -152.62% +28.31%
Net Margin Growth
- - -0.43% -0.23%
-
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
8.39M 10.53M (5.54M) (3.97M)
Preferred Dividends
- - 3.58M 5.55M
-
Net Income Available to Common
8.39M 10.53M (9.12M) (9.52M)
EPS (Basic)
0.2014 0.2526 -1.3647 -0.6942
EPS (Basic) Growth
- +25.42% -640.26% +49.13%
Basic Shares Outstanding
41.69M 41.69M 6.69M 13.72M
EPS (Diluted)
0.2014 0.2526 -1.3647 -0.6942
EPS (Diluted) Growth
- +25.42% -640.26% +49.13%
Diluted Shares Outstanding
41.69M 41.69M 6.69M 13.72M
EBITDA
(1.63M) (2.39M) (1.18M) 3.28M
EBITDA Growth
- -46.40% +50.67% +378.20%
EBITDA Margin
- - -0.09% +0.19%
-

American Oncology Network Inc in the News